Lab Members

Education : PhD in Experimental Medicine, University of McGill, Canada.

Current research : Genome-wide CRISPR/CAS9 loss-of-function screening for new cancer drug target discovery and biomarkers of drug resistance.

• Education : PhD.
• Current research : My research focuses on pre-clinic experiments to investigate human cancerous processes and mechanisms by using immunodeficient laboratory mouse models (breast cancer, pancreas cancer, lung and liver metastases, etc.) in order to explore and develop novel therapies for cancer treatment.

• Education : B.Sc. in Biopharmaceutical Sciences, Université de Montréal.
• Current research : Evaluation of the therapeutic potential of a certain TGFb-mediated microRNA found to be upregulated in triple negative breast cancer. This is being tested in vitro as well as in vivo using CRISPR/Cas technology.

Defining the role of CDK6 and DNA repair pathways in tumorigenesis and identify CDK4/6-dependent synthetic lethal vulnerabilities in triple negative breast cancer.

Education : M.Sc. in Molecular Biology at the University of Sherbrooke.

Current Research : The production of genetically modified cancer cell lines using the CRISPR technology and the cytotoxic study of kinase inhibitors in breast cancer.

Education : B.Sc. in Biochemistry and Molecular Biology, Northeast Agricultural University, China.

Current research : Utilizing genome-wide Crispr/Cas9 screen based on paclitaxel to identify key genetic mutations responsible for paclitaxel resistance in triple negative breast cancer.

Program Assistant, Cancer Research Program (CRP)